Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial.
|
J Urol
|
2010
|
2.68
|
2
|
Artificial urinary sphincter revision: the role of ultrasound.
|
Urology
|
2013
|
2.62
|
3
|
Contemporary management of postprostatectomy incontinence.
|
Eur Urol
|
2011
|
2.01
|
4
|
An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients.
|
J Urol
|
2003
|
1.73
|
5
|
Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach.
|
J Urol
|
2008
|
1.67
|
6
|
Urodynamic studies in adults: AUA/SUFU guideline.
|
J Urol
|
2012
|
1.51
|
7
|
Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction.
|
Rev Urol
|
2005
|
1.49
|
8
|
Artificial urinary sphincter versus male sling for post-prostatectomy incontinence--what do patients choose?
|
J Urol
|
2009
|
1.30
|
9
|
American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life.
|
Urology
|
2003
|
1.30
|
10
|
Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability.
|
Neurourol Urodyn
|
2013
|
1.17
|
11
|
Comparison of diagnostic criteria for female bladder outlet obstruction.
|
J Urol
|
2006
|
1.14
|
12
|
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study.
|
Mayo Clin Proc
|
2008
|
1.11
|
13
|
Review article: Mid-urethral synthetic slings for female stress urinary incontinence.
|
BJU Int
|
2010
|
1.10
|
14
|
Female urethral reconstruction.
|
Urol Clin North Am
|
2011
|
1.01
|
15
|
Female stress urinary incontinence: how do patient and physician perspectives correlate in assessment of outcomes?
|
Curr Opin Urol
|
2006
|
0.99
|
16
|
The male perineal sling: assessment and prediction of outcome.
|
J Urol
|
2007
|
0.95
|
17
|
Surgical management of Skene's gland abscess/infection: a contemporary series.
|
Int Urogynecol J
|
2011
|
0.95
|
18
|
Effect of tension-free vaginal tape and TVT-obturator on lower urinary tract symptoms other than stress urinary incontinence.
|
Int Urogynecol J Pelvic Floor Dysfunct
|
2007
|
0.94
|
19
|
Comparison between reduction in 24-hour pad weight, International Consultation on Incontinence-Short Form (ICIQ-SF) score, International Prostate Symptom Score (IPSS), and Post-Operative Patient Global Impression of Improvement (PGI-I) score in patient evaluation after male perineal sling.
|
Neurourol Urodyn
|
2007
|
0.94
|
20
|
A urodynamics protocol to optimally assess men with post-prostatectomy incontinence.
|
Neurourol Urodyn
|
2005
|
0.90
|
21
|
Primary bladder neck obstruction in men and women.
|
Rev Urol
|
2005
|
0.90
|
22
|
Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art.
|
Rev Urol
|
2006
|
0.90
|
23
|
Urinary incontinence.
|
Prim Care
|
2010
|
0.88
|
24
|
Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms.
|
Urology
|
2002
|
0.87
|
25
|
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder.
|
Int Urogynecol J
|
2014
|
0.87
|
26
|
Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding.
|
J Urol
|
2011
|
0.87
|
27
|
Patient perception of videourodynamic testing: a questionnaire based study.
|
J Urol
|
2005
|
0.86
|
28
|
Clinical impact of overactive bladder.
|
Rev Urol
|
2002
|
0.85
|
29
|
Midurethral slings for all stress incontinence: a urology perspective.
|
Urol Clin North Am
|
2012
|
0.85
|
30
|
Management of recurrent urinary tract infections in healthy adult women.
|
Rev Urol
|
2013
|
0.84
|
31
|
Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction.
|
J Urol
|
2003
|
0.84
|
32
|
Defining efficacy in the treatment of overactive bladder syndrome.
|
Rev Urol
|
2009
|
0.84
|
33
|
Management of obstructive voiding dysfunction after incontinence surgery: lessons learned.
|
Urology
|
2003
|
0.83
|
34
|
Degree of bother caused by nocturia in women.
|
Neurourol Urodyn
|
2004
|
0.83
|
35
|
Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures?
|
J Urol
|
2010
|
0.81
|
36
|
Efficacy and tolerability of fesoterodine in women with overactive bladder.
|
Int Urogynecol J Pelvic Floor Dysfunct
|
2009
|
0.81
|
37
|
Bladder-health diaries: an assessment of 3-day vs 7-day entries.
|
BJU Int
|
2005
|
0.81
|
38
|
Recent advances in management of female lower urinary tract trauma.
|
Curr Opin Urol
|
2003
|
0.80
|
39
|
Primary bladder neck obstruction in men, women, and children.
|
Curr Urol Rep
|
2007
|
0.80
|
40
|
Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women.
|
Urology
|
2012
|
0.80
|
41
|
Duloxetine: a new pharmacologic therapy for stress urinary incontinence.
|
Rev Urol
|
2004
|
0.79
|
42
|
Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings.
|
Int Urogynecol J Pelvic Floor Dysfunct
|
2004
|
0.78
|
43
|
Long-term continence after surgery--what can we tell patients?
|
J Urol
|
2012
|
0.78
|
44
|
Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder.
|
Urology
|
2008
|
0.78
|
45
|
Diagnosis and treatment of primary bladder neck obstruction in men.
|
Curr Urol Rep
|
2005
|
0.77
|
46
|
Comparison of urodynamic findings in women with anatomical versus functional bladder outlet obstruction.
|
Female Pelvic Med Reconstr Surg
|
2013
|
0.77
|
47
|
Can noninvasive evaluation of benign prostatic obstruction be optimized?
|
Curr Opin Urol
|
2012
|
0.77
|
48
|
Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder.
|
World J Urol
|
2014
|
0.77
|
49
|
Tolterodine for treatment of overactive bladder.
|
Urol Clin North Am
|
2006
|
0.76
|
50
|
Correlation of abdominal leak point pressure with objective incontinence severity in men with post-radical prostatectomy stress incontinence.
|
Neurourol Urodyn
|
2005
|
0.76
|
51
|
Endoscopic evacuation of Durasphere.
|
Urology
|
2003
|
0.76
|
52
|
Reply: To PMID 24295256.
|
Urology
|
2013
|
0.75
|
53
|
Urodynamics for clinically suspected obstruction after anti-incontinence surgery in women.
|
J Urol
|
2013
|
0.75
|
54
|
Editorial comment.
|
Urology
|
2011
|
0.75
|
55
|
Transdermal therapy for overactive bladder: present and future.
|
Rev Urol
|
2003
|
0.75
|
56
|
Editorial comment.
|
Urology
|
2011
|
0.75
|
57
|
Is There a Role for alpha-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia?
|
Rev Urol
|
2005
|
0.75
|
58
|
Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling.
|
J Urol
|
2009
|
0.75
|
59
|
Management of urinary retention and obstruction following surgery for stress urinary incontinence.
|
Curr Urol Rep
|
2002
|
0.75
|
60
|
Vaginal granulation tissue secondary to bone anchors: experience in two patients.
|
J Urol
|
2003
|
0.75
|
61
|
Urodynamic findings in women with insensible incontinence.
|
Int J Urol
|
2012
|
0.75
|
62
|
Fistulization between ectopic ureteral stump and uterus following nephroureterectomy: case report.
|
Int Urogynecol J Pelvic Floor Dysfunct
|
2009
|
0.75
|
63
|
Pelvic floor reconstruction: state-of-the-art and beyond.
|
Urol Clin North Am
|
2004
|
0.75
|